1. Aman, P., Ehlin-Henriksson, B., and Klein, G., 1984, Epstein—Barr virus susceptibility of normal human B lymphocyte populations, J. Exp. Med.
159: 208–220.
2. Callard, R. E., 1979, Specific in vitro antibody response to influenza virus by human blood lymphocytes, Nature
282: 734–736.
3. Clarke, C. A., Donohue, W. T. A., McConnell, R. B., Woodrow, J. C., Finn, R., Krevans, J. R., Kulke, W., Lehare, D., and Sheppard, P. M., 1963, Further experimental studies on the prevention of Rh haemolytic disease, Br. Med. J.
1: 979.
4. Crawford, D. H., 1981, Lymphomas after cyclosporin A treatment, in: Transplantation and Clinical Immunology XIII U. T. Touraine, J. Traeger, H. Betuel, J. Brochier, J. M. Dubernard, J. P. Revillard, and R. Triau, eds.), Excerpta Medica, Amsterdam pp. 48–52.
5. Crawford, D. H., Callard, R. E., Muggeridge, M. I., Mitchell, D. M., Zanders, E. D., and Beverley, P. C. L., 1983a, Production of human monoclonal antibody to X31 influenza virus nucleoprotein, J. Gen Virol.
64: 697–700.